PURPOSE: To investigate whether photodynamic diagnosis (PDD)-guided bladder tumour resection (TUR-BT) is of prognostic value in patients undergoing subsequent radical cystectomy (RC) for bladder cancer (BC). METHODS: In 224 consecutive patients who underwent RC and bilateral pelvic lymphadenectomy for BC between 2002 and 2010 (median follow-up 29 months [IQR 8-59]), we retrospectively investigated whether patients had previously undergone PDD-guided (hexaminolevulinate [HAL] vs. 5-aminolevulinate [ALA]) versus white light (WL)-TUR-BT. Kaplan-Meier analysis was used to estimate recurrence-free survival (RFS), cancer-specific survival (CSS) and overall survival (OS) using log-rank and Cox regression model for uni- and multivariable analysis. RESULTS: Of the 224 patients, 66 (29.5 %) underwent HAL-, 23 (10.3 %) ALA- and 135 (60.2 %) WL-TUR-BT before RC. The 3-year RFS/CSS/OS was 77.8/83.9/74.0 % for HAL-, 53.6/74.5/60.9 % for ALA- and 52.4/59.7/56.5 % for WL-TUR-BT (p = 0.002/0.023/0.037 for HAL vs. WL/ALA). PDD-TUR-BT was associated with a higher number of TUR-BTs before RC (p < 0.001) and re-resections (p = 0.015), a longer time between the first TUR-BT and RC (p = 0.044) and a lower rate of post-operative systemic chemotherapy (p = 0.001). In multivariable analysis, performance of HAL-TUR-BT, pathologic tumour and nodal stage as well as soft tissue surgical margin status were independent predictors for RFS, CSS and OS. CONCLUSIONS: This series indicates for the first time that HAL-guided TUR-BT is an independent predictor for improved survival after RC.
PURPOSE: To investigate whether photodynamic diagnosis (PDD)-guided bladder tumour resection (TUR-BT) is of prognostic value in patients undergoing subsequent radical cystectomy (RC) for bladder cancer (BC). METHODS: In 224 consecutive patients who underwent RC and bilateral pelvic lymphadenectomy for BC between 2002 and 2010 (median follow-up 29 months [IQR 8-59]), we retrospectively investigated whether patients had previously undergone PDD-guided (hexaminolevulinate [HAL] vs. 5-aminolevulinate [ALA]) versus white light (WL)-TUR-BT. Kaplan-Meier analysis was used to estimate recurrence-free survival (RFS), cancer-specific survival (CSS) and overall survival (OS) using log-rank and Cox regression model for uni- and multivariable analysis. RESULTS: Of the 224 patients, 66 (29.5 %) underwent HAL-, 23 (10.3 %) ALA- and 135 (60.2 %) WL-TUR-BT before RC. The 3-year RFS/CSS/OS was 77.8/83.9/74.0 % for HAL-, 53.6/74.5/60.9 % for ALA- and 52.4/59.7/56.5 % for WL-TUR-BT (p = 0.002/0.023/0.037 for HAL vs. WL/ALA). PDD-TUR-BT was associated with a higher number of TUR-BTs before RC (p < 0.001) and re-resections (p = 0.015), a longer time between the first TUR-BT and RC (p = 0.044) and a lower rate of post-operative systemic chemotherapy (p = 0.001). In multivariable analysis, performance of HAL-TUR-BT, pathologic tumour and nodal stage as well as soft tissue surgical margin status were independent predictors for RFS, CSS and OS. CONCLUSIONS: This series indicates for the first time that HAL-guided TUR-BT is an independent predictor for improved survival after RC.
Authors: J P Stein; G Lieskovsky; R Cote; S Groshen; A C Feng; S Boyd; E Skinner; B Bochner; D Thangathurai; M Mikhail; D Raghavan; D G Skinner Journal: J Clin Oncol Date: 2001-02-01 Impact factor: 44.544
Authors: Arnulf Stenzl; Hannes Penkoff; Elfriede Dajc-Sommerer; Andreas Zumbraegel; Lorenz Hoeltl; Michael Scholz; Claus Riedl; Josef Bugelnig; Alfred Hobisch; Maximilian Burger; Gregor Mikuz; Uwe Pichlmeier Journal: Cancer Date: 2010-11-08 Impact factor: 6.860
Authors: Michael Rink; Marko Babjuk; James W F Catto; Patrice Jichlinski; Shahrokh F Shariat; Arnulf Stenzl; Herbert Stepp; Dirk Zaak; J Alfred Witjes Journal: Eur Urol Date: 2013-07-19 Impact factor: 20.096
Authors: Arnulf Stenzl; Maximilian Burger; Yves Fradet; Lance A Mynderse; Mark S Soloway; J Alfred Witjes; Martin Kriegmair; Alexander Karl; Yu Shen; H Barton Grossman Journal: J Urol Date: 2010-09-17 Impact factor: 7.450
Authors: Shahrokh F Shariat; Robert S Svatek; Derya Tilki; Eila Skinner; Pierre I Karakiewicz; Umberto Capitanio; Patrick J Bastian; Bjoern G Volkmer; Wassim Kassouf; Giacomo Novara; Hans-Martin Fritsche; Jonathan I Izawa; Vincenzo Ficarra; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ashish M Kamat; Colin P Dinney; Yair Lotan; Michael J Marberger; Yves Fradet Journal: BJU Int Date: 2010-02-02 Impact factor: 5.588
Authors: Georgios Gakis; Jason Efstathiou; Seth P Lerner; Michael S Cookson; Kirk A Keegan; Khurshid A Guru; William U Shipley; Axel Heidenreich; Mark P Schoenberg; Arthur I Sagaloswky; Mark S Soloway; Arnulf Stenzl Journal: Eur Urol Date: 2012-08-14 Impact factor: 20.096
Authors: Daniel Canter; Thomas J Guzzo; Matthew J Resnick; Benjamin Brucker; Manish Vira; Zhen Chen; John Tomaszewski; Keith VanArsdalen; Alan J Wein; S Bruce Malkowicz Journal: Urology Date: 2008-06-02 Impact factor: 2.649
Authors: H Barton Grossman; Arnulf Stenzl; Yves Fradet; Lance A Mynderse; Martin Kriegmair; J Alfred Witjes; Mark S Soloway; Alexander Karl; Maximilian Burger Journal: J Urol Date: 2012-05-12 Impact factor: 7.450
Authors: J Alfred Witjes; Eva Compérat; Nigel C Cowan; Maria De Santis; Georgios Gakis; Thierry Lebret; Maria J Ribal; Antoine G Van der Heijden; Amir Sherif Journal: Eur Urol Date: 2013-12-12 Impact factor: 20.096
Authors: Atiqullah Aziz; Michael Gierth; Michael Rink; Marianne Schmid; Felix K Chun; Roland Dahlem; Florian Roghmann; Rein-Jüri Palisaar; Joachim Noldus; Jörg Ellinger; Stefan C Müller; Armin Pycha; Thomas Martini; Christian Bolenz; Rudolf Moritz; Edwin Herrmann; Bastian Keck; Bernd Wullich; Roman Mayr; Hans-Martin Fritsche; Maximilian Burger; Patrick J Bastian; Christian Seitz; Sabine Brookman-May; Evanguelos Xylinas; Shahrokh F Shariat; Margit Fisch; Matthias May Journal: World J Urol Date: 2015-05-07 Impact factor: 4.226
Authors: Markus Renninger; Omar Fahmy; Tina Schubert; Manuel Alexander Schmid; Fahmy Hassan; Arnulf Stenzl; Georgios Gakis Journal: World J Urol Date: 2019-04-27 Impact factor: 4.226
Authors: Matthias May; Hans-Martin Fritsche; Malte W Vetterlein; Patrick J Bastian; Michael Gierth; Philipp Nuhn; Atiqullah Aziz; Margit Fisch; Christian G Stief; Markus Hohenfellner; Manfred P Wirth; Vladimir Novotny; Oliver W Hakenberg; Joachim Noldus; Christian Gilfrich; Christian Bolenz; Maximilian Burger; Sabine D Brookman-May Journal: World J Urol Date: 2016-06-14 Impact factor: 4.226
Authors: Jean de la Rosette; Alexey Martov; Rodolfo Hurle; Gabriel Favre; Charalampos Mamoulakis; Manuel Castanheira de Oliveira; Arnulf Stenzl; Estefania Linares-Espinós; Carlos R Trelles Guzmán; Stavros Gravas; Thomas Knoll; Mustafa Yucel Boz; Thomas Herrmann; Pilar Laguna Journal: World J Urol Date: 2021-11-06 Impact factor: 4.226